Atrium Biotechnologies Loses Name, Gains Board Member

Company is now Atrium Innovations; Carole St-Charles joins the Board.

QUEBEC CITY, Canada - Atrium Biotechnologies Inc. changed its name Thursday to Atrium Innovations Inc.

The name change is designed to reflect the company’s transition from a subsidiary of a biotechnology company to a multi product manufacturer and marketer and integrated international company.

Pierre Laurin, Chairman of the Board, also announced that Carole St-Charles was appointed to the Board of Atrium Innovations. St-Charles is the president of food and OTC healthcare products company Consortium J.L.F. Inc.

Atrium Innovations develops, manufactures and markets science-based products for the cosmetics, pharmaceutical, chemical and nutrition industries.